Treatment of nmCRPC: comorbidities and DDIs
Oncología

Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug-drug interactions

28 Dec, 2023

David Conde-Estévez, Iván Henríquez, Jesús Muñoz-Rodríguez, Alejo Rodriguez-Vida. Expert Opin Drug Metab Toxicol. 2022 Sep;18(9):601-613.

Related Content
Darolutamide + ADT + Docetaxel in mHSPC by Subgroups
CPHSm
Informe SEOM de evaluación de darolutamida en CPRCnm
CPRCnm